Stay updated on Nivolumab in IDH-Mutant Gliomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.
Latest updates to the Nivolumab in IDH-Mutant Gliomas Clinical Trial page
- Check5 days agoChange DetectedThe Study Record Dates section now shows 'Results First Posted (Estimated)' and 'Last Update Posted (Estimated)', replacing the previous labels.SummaryDifference0.1%
- Check12 days agoChange DetectedAdded a Results Posted entry with attribution to the National Cancer Institute (NCI) and Jing Wu, M.D., dated 2025-11-24, and expanded study results content; removed the NIH Clinical Center location and the 'Results Submitted' text.SummaryDifference6%
- Check20 days agoChange DetectedThe funding-lapse warning text was removed from the page. Previously, the notice warned that information may not be up to date and that operations might be disrupted until appropriations are enacted.SummaryDifference0.4%
- Check34 days agoChange DetectedMinor formatting and layout updates across the page; no changes to core study data such as eligibility criteria, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check63 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%
- Check70 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%
Stay in the know with updates to Nivolumab in IDH-Mutant Gliomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.